Logo image of CDTX

CIDARA THERAPEUTICS INC (CDTX) Stock Analyst Ratings

NASDAQ:CDTX - Nasdaq - US1717572069 - Common Stock - Currency: USD

44.95  +23.93 (+113.84%)

After market: 45 +0.05 (+0.11%)

Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to CDTX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 42.16. This target is -6.21% below the current price.
CDTX was analyzed by 13 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about CDTX.
In the previous month the buy percentage consensus was at a similar level.
CDTX was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
CDTX Historical Analyst RatingsCDTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -102 -92 -82 -72 -62 -52 -42 -32 -22 -12 -2 5 10

Price Target & Forecast

Price Low Median Mean High 44.9535.3541.3142.1652.50 - -21.36% -8.10% -6.21% 16.80%
CDTX Current Analyst RatingCDTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades
Date Firm Action Rating
2025-06-23 WBB Securities Reiterate Strong Buy -> Strong Buy
2025-06-23 Needham Maintains Buy -> Buy
2025-06-10 Cantor Fitzgerald Reiterate Overweight -> Overweight
2025-06-04 Needham Maintains Buy -> Buy
2025-06-02 JMP Securities Reiterate Market Outperform -> Market Outperform
2025-05-27 JMP Securities Reiterate Market Outperform -> Market Outperform
2025-05-23 Needham Reiterate Buy -> Buy
2025-05-23 RBC Capital Maintains Outperform -> Outperform
2025-05-16 Guggenheim Maintains Buy -> Buy
2025-05-09 Guggenheim Maintains Buy -> Buy
2025-05-09 JMP Securities Maintains Market Outperform -> Market Outperform
2025-04-29 JMP Securities Reiterate Market Outperform -> Market Outperform
2025-04-10 Needham Reiterate Buy -> Buy
2025-03-12 Citizens Capital Markets Initiate Market Outperform
2025-03-10 HC Wainwright & Co. Maintains Buy -> Buy
2025-03-07 Needham Reiterate Buy -> Buy
2024-12-13 RBC Capital Initiate Outperform
2024-12-05 WBB Securities Maintains Strong Buy -> Strong Buy
2024-11-11 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-08 Guggenheim Initiate Buy
2024-10-22 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-14 Cantor Fitzgerald Reiterate Overweight
2024-08-14 Needham Reiterate Buy -> Buy
2024-08-14 HC Wainwright & Co. Upgrade Neutral -> Buy
2024-06-20 Cantor Fitzgerald Reiterate Overweight
2024-05-16 Needham Reiterate Buy -> Buy
2024-04-25 WBB Securities Maintains Strong Buy -> Strong Buy
2024-04-25 Cantor Fitzgerald Reiterate Overweight
2024-04-25 Needham Maintains Buy -> Buy